Accession Number:

ADB165323

Title:

Microencapsulation of Drugs in the Microgravity Environment of the United States Space Shuttle.

Descriptive Note:

Annual rept. 15 Apr 91-14 Apr 92,

Corporate Author:

SOUTHERN RESEARCH INST BIRMINGHAM AL

Personal Author(s):

Report Date:

1992-06-11

Pagination or Media Count:

26.0

Abstract:

Equipment has been designed and constructed to produce pharmaceutical microspheres in the microgravitational environment found aboard an orbiting U.S. Space Shuttle. The microcapsules in space MIS equipment will replace two space shuttle middeck storage lockers. Design changes have been incorporated into the MIS equipment reflecting the results of NASA mandated safety tests. MIS is tentatively manifested aboard the Space Shuttle Discovery on Mission STS-53 pending final safety certification by NASA. STS-53 is scheduled for launch on October 15, 1992. RA 2 Microencapsulation Controlled-release Space Shuttle Antibiotics Drug development.

Subject Categories:

  • Pharmacology
  • Manned Spacecraft

Distribution Statement:

APPROVED FOR PUBLIC RELEASE